Farmaci, oftalmologo Rossetti: "Con Ntc sviluppati prodotti italiani di rilievo internazionale"
Italian company Ntc and a Milan university clinic developed internationally recognized eye care products through a major research collaboration.
Reported by Adnkronos - ultimoratop · context written by Hushread
In brief
- Ntc, an Italian pharmaceutical company, partnered with San Paolo University Clinic in Milan to develop new ophthalmic products.
- The collaboration involved many patients in clinical trials and resulted in scientific publications in respected international journals.
- A key outcome was the fixed combination of an antibiotic and a non-steroidal anti-inflammatory drug for eye care.
- This product, developed from the start at the Milan institute with Ntc, is now sold in many countries.
- The partnership highlights the international impact of Italian research and pharmaceutical innovation in ophthalmology.
What happened
Luca Rossetti, director of the university clinic at San Paolo Hospital in Milan, described a successful collaboration with the Italian pharmaceutical company Ntc. Together, they developed new ophthalmic products, involved many patients in research, and published findings in top international journals.
Why it matters
This collaboration has helped bring Italian-developed eye care products to a global market, benefiting patients worldwide. It also demonstrates the strength of Italian research and its ability to influence international medical practice, especially in ophthalmology.
How we got here
Ntc is a leading Italian company in the field of ophthalmology. For ten years, it has worked with the university clinic at San Paolo Hospital in Milan. Their joint efforts included clinical trials with many patients and resulted in scientific articles and new drug combinations, such as an antibiotic with a non-steroidal anti-inflammatory.
What happens next
It is expected that the partnership will continue to focus on developing and distributing innovative ophthalmic products internationally, with further research and clinical studies likely.